Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
3.540
+0.060 (1.72%)
At close: Sep 22, 2026, 4:00 PM EDT
3.570
+0.030 (0.85%)
After-hours: Sep 22, 2026, 7:41 PM EDT
Genprex Market Cap
Genprex has a market cap or net worth of $2.9 million as of September 22, 2026. Its market cap has decreased by -62.80% in one year.
Market Cap
2.90M
Enterprise Value
-12.25M
1-Year Change
-62.80%
Ranking
Category
Stock Price
$3.54
ChartMarket Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $11.40M to $2.90M, a decrease of -74.55%. That is a compound annual growth rate of -14.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 2.90M | -27.46% |
| Dec 31, 2025 | 4.00M | -44.44% |
| Dec 31, 2024 | 7.20M | -47.45% |
| Dec 29, 2023 | 13.70M | -80.32% |
| Dec 30, 2022 | 69.60M | 11.00% |
| Dec 31, 2021 | 62.70M | -61.84% |
| Dec 31, 2020 | 164.30M | 3,121.57% |
| Dec 31, 2019 | 5.10M | -69.28% |
| Dec 31, 2018 | 16.60M | 45.61% |
| Mar 29, 2018 | 11.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 60 Degrees Pharmaceuticals | 3.36M |
| Aptevo Therapeutics | 3.32M |
| GeoVax Labs | 3.25M |
| Addex Therapeutics | 3.22M |
| Alaunos Therapeutics | 3.05M |
| Silo Pharma | 2.92M |
| Clearmind Medicine | 2.69M |
| SciSparc | 2.62M |